Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchoprotection of Tiotropium vs Glycopyrronium in Asthma
NCT02622243Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing tiotropium with glycopyrronium (2 arms). Primary endpoint: Change from baseline methacholine bronchoprotection at 96 hours. Started Nov 2015; status: completed.
02
Drugs
tiotropiumglycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02622243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622243.